{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:56:05Z","timestamp":1790193365320,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00669"],"award-info":[{"award-number":["PI17\/00669"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gender differences in organ involvement and clinical severity have been poorly described in hereditary hemorrhagic telangiectasia (HHT). The aim of this study was to describe differences in the severity of HHT manifestations according to gender.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Severity was measured according to Epistaxis Severity Score (ESS), Simple Clinical Scoring Index for hepatic involvement, a general HHT-score, needing for invasive treatment (pulmonary or brain arteriovenous malformations -AVMs- embolization, liver transplantation or Young\u2019s surgery) or the presence of adverse outcomes (severe anemia, emergency department -ED- or hospital admissions and mortality).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred forty-two (58.7%) women and 100 (41.3%) men were included with a mean age of 48.9\u2009\u00b1\u200916.6 and 49\u2009\u00b1\u200916.5\u2009years, respectively. Women presented hepatic manifestations (7.1% vs 0%) and hepatic involvement (59.8% vs 47%), hepatic AVMs (28.2% vs 13%) and bile duct dilatation (4.9% vs 0%) at abdominal CT, and pulmonary AVMs at thoracic CT (35.2% vs 23%) more often than men. The Simple Clinical Scoring Index was higher in women (3.38\u2009\u00b1\u20091.2 vs 2.03\u2009\u00b1\u20091.2), and more men were considered at low risk of harboring clinically significant liver disease than women (61% vs 25.3%). These differences were mantained when considering HHT1 and HHT2 patients separetely. Duodenal telangiectasia were more frequent in men than women (21% vs 9.8%). Invasive treatments were more frequently needed in women (28.2% vs 16%) but men needed attention at the ED more often than women (48% vs 28.2%), with no differences in ESS, HHT-score, anemia hospital admissions or mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HHT women showed more severe hepatic involvement than men, also among HHT1 and HHT2 patients. Women had higher prevalence of pulmonary AVMs and needed invasive procedures more frequently, while men needed attention at the ED more often. These data might help physicians to individualize HHT patients follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-1337-5","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:02:51Z","timestamp":1583175771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Gender differences in hereditary hemorrhagic telangiectasia severity"],"prefix":"10.1186","volume":"15","author":[{"given":"J. M.","family":"Mora-Luj\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"S\u00e1nchez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cerd\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cruellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Ordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Corbella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Castellote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-804X","authenticated-orcid":false,"given":"A.","family":"Riera-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"1337_CR1","unstructured":"The portal for rare diseases and orphan drugs. Available online: https:\/\/www.orpha.net\/consor\/cgi-bin\/index.php (Accessed on 22 July 2019)."},{"key":"1337_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009;17:860\u201371.","journal-title":"Eur J Hum Genet"},{"key":"1337_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852\u20139.","journal-title":"Lancet."},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2015.00001","volume":"6","author":"J McDonald","year":"2015","unstructured":"McDonald J, Wooderchak-Donahue W, VanSant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015;6:1.","journal-title":"Front Genet"},{"key":"1337_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jmg.2006.042606","volume":"43","author":"NL Prigoda","year":"2006","unstructured":"Prigoda NL, Savas S, Abdalla SA, Piovesan B, Rushlow D, Vandezande K, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet. 2006;43:722\u20138.","journal-title":"J Med Genet"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","volume":"9","author":"G Lesca","year":"2007","unstructured":"Lesca G, Olivieri C, Burnichon N, Pagella F, Carette M-F, Gilbert-Dussardier B, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med. 2007;9:14\u201322.","journal-title":"Genet Med"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fgene.2014.00456","volume":"5","author":"E Tillet","year":"2015","unstructured":"Tillet E, Bailly S. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. Front Genet. 2015;5:456.","journal-title":"Front Genet"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu- Osler-weber syndrome). Am J Med Genet. 2000;91:66\u20137.","journal-title":"Am J Med Genet"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13023-018-0850-2","volume":"13","author":"CL Shovlin","year":"2018","unstructured":"Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, et al. European reference network for rare vascular diseases (VASCERN) outcome measures for hereditary Haemorrhagic telangiectasia (HHT). Orphanet J Rare Dis. 2018;13:136.","journal-title":"Orphanet J Rare Dis"},{"key":"1337_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73\u201387.","journal-title":"J Med Genet"},{"key":"1337_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1523-1747.ep12555569","volume":"95","author":"IM Braverman","year":"1990","unstructured":"Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol. 1990;95:422\u20137.","journal-title":"J Invest Dermatol"},{"key":"1337_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2013-203720","volume":"69","author":"JW Donaldson","year":"2014","unstructured":"Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax. 2014;69:161\u20137..","journal-title":"Thorax."},{"key":"1337_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.rce.2018.07.002","volume":"218","author":"A Riera-Mestre","year":"2018","unstructured":"Riera-Mestre A, Mora Luj\u00e1n JM, Sanchez Mart\u00ednez R, Torralba Cabeza MA, de la Pe\u00f1a JL P, Juyol Rodrigo MC, et al. Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa Registry) in Spain: Objectives, methods, and preliminary results. Rev Clin Esp. 2018;218:468\u201376.","journal-title":"Rev Clin Esp"},{"key":"1337_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ajmg.a.31101","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet. 2006;140:463\u201370.","journal-title":"Am J Med Genet"},{"key":"1337_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/gim.2014.5","volume":"16","author":"KE Wain","year":"2014","unstructured":"Wain KE, Ellingson MS, McDonald J, Gammon A, Roberts M, Pichurin P, et al. Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Genet Med. 2014;16:588\u201393.","journal-title":"Genet Med."},{"key":"1337_CR16","doi-asserted-by":"publisher","first-page":"e8812","DOI":"10.1371\/journal.pone.0088812","volume":"9","author":"CL Shovlin","year":"2014","unstructured":"Shovlin CL, Chamali B, Santhirapala V, Livesey JA, Angus G, Manning R, et al. Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets. PLoS One. 2014;9:e8812.","journal-title":"PLoS One"},{"key":"1337_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/thx.2007.087452","volume":"63","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, et al. Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 2008;63:259\u201366.","journal-title":"Thorax."},{"key":"1337_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/GIM.0b013e3182136d32","volume":"13","author":"J McDonald","year":"2011","unstructured":"McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management and pathogenesis. Genet Med. 2011;13:607\u201316.","journal-title":"Genet Med."},{"key":"1337_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jhep.2014.02.028","volume":"61","author":"S Singh","year":"2014","unstructured":"Singh S, Swanson KL, Hathcock MA, Kremers WK, Pallanch JF, Krowka MJ, et al. Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index. J Hepatol. 2014;61:124\u201331.","journal-title":"J Hepatol"},{"key":"1337_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MCP.0000000000000472","volume":"24","author":"S Kroon","year":"2018","unstructured":"Kroon S, Snijder RJ, Faughnan ME, Mager H-J. Systematic screening in hereditary hemorrhagic telangiectasia: a review. Curr Opin Pulm Med. 2018;24:260\u20138.","journal-title":"Curr Opin Pulm Med"},{"key":"1337_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ajmg.a.10002","volume":"116","author":"CJ Westermann","year":"2003","unstructured":"Westermann CJ, Rosina AF, De Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A. 2003;116:324\u20138.","journal-title":"Am J Med Genet A"},{"key":"1337_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/gim.2013.66","volume":"16","author":"SD Grosse","year":"2014","unstructured":"Grosse SD, Boulet SL, Grant AM, Hulihan MM, Faughnan ME. The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia. Genet Med. 2014;16:33\u20139.","journal-title":"Genet Med."},{"key":"1337_CR23","first-page":"108","volume":"55","author":"N Kapur","year":"2005","unstructured":"Kapur N, Hunt I, Lunt M, McBeth J, Creed F, Macfarlane G. Primary care consultation predictors in men and women: a cohort study. Br J Gen Pract. 2005;55:108\u201313.","journal-title":"Br J Gen Pract"},{"key":"1337_CR24","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/01.sla.0000247258.35406.a4","volume":"244","author":"J Lerut","year":"2006","unstructured":"Lerut J, Orlando G, Adam R, Sabb\u00e0 C, Pfitzmann R, Klempnauer J, et al. Liver transplantation for hereditary hemorrhagic telangiectasia: report of the European liver transplant registry. Ann Surg. 2006;244:854\u201362.","journal-title":"Ann Surg"},{"key":"1337_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13023-014-0188-3","volume":"9","author":"GA Latino","year":"2014","unstructured":"Latino GA, Kim H, Nelson J, Pawlikowska L, Young W, Faughnan ME. Severity score for hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2014;9:188.","journal-title":"Orphanet J Rare Dis."},{"key":"1337_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806\u20138.","journal-title":"BMJ."},{"key":"1337_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.medcli.2018.09.015","volume":"152","author":"A Riera-Mestre","year":"2019","unstructured":"Riera-Mestre A, Ribas J, Castellote J. Medical management of haemorrhagic hereditary telangiectasia in adult patients. Med Clin. 2019;152:274\u201380.","journal-title":"Med Clin"},{"key":"1337_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0028-1085093","volume":"28","author":"SK Khalid","year":"2008","unstructured":"Khalid SK, Garcia-tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis. 2008;28:247\u201358.","journal-title":"Semin Liver Dis"},{"key":"1337_CR29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/0002-9149(91)90287-U","volume":"68","author":"B Barzilai","year":"1991","unstructured":"Barzilai B, Waggoner AD, Spessert C, Picus D, Goodenberger D. Two-dimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformations. Am J Cardiol. 1991;68:1507\u201310.","journal-title":"Am J Cardiol"},{"key":"1337_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lary.20818","volume":"120","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010;120:838\u201343.","journal-title":"Laryngoscope."},{"key":"1337_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2500\/ajra.2012.26.3809","volume":"26","author":"SL Richer","year":"2012","unstructured":"Richer SL, Geisthoff UW, Livada N, Ward PD, Johnson L, Mainka A, et al. The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia. Am J Rhinol Allergy. 2012;26:401\u20134.","journal-title":"Am J Rhinol Allergy"},{"key":"1337_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.hpb.2017.03.005","volume":"19","author":"E Felli","year":"2017","unstructured":"Felli E, Addeo P, Faitot F, Nappo G, Oncioiu C, Bachellier P. Liver transplantation for hereditary hemorrhagic telangiectasia: a systematic review. HPB. 2017;19:567\u201372.","journal-title":"HPB."},{"key":"1337_CR33","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/hep.30424","volume":"69","author":"J Dumortier","year":"2019","unstructured":"Dumortier J, Dupuis-Girod S, Valette PJ, Valent A, Guillaud O, Saurin JC, et al. Recurrence of hereditary hemorrhagic telangiectasia after liver transplantation: clinical implications and physiopathological insights. Hepatology. 2019;69:2232\u201340.","journal-title":"Hepatology."},{"key":"1337_CR34","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/TP.0000000000002491","volume":"103","author":"VN Iyer","year":"2019","unstructured":"Iyer VN, Saberi B, Heimbach JK, Larson JJ, Raghavaiah S, Ditah I, et al. Liver transplantation trends and outcomes for hereditary hemorrhagic telangiectasia in the United States. Transplantation. 2019;103:1418\u201324.","journal-title":"Transplantation."},{"key":"1337_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00330-017-5047-x","volume":"28","author":"J Etievant","year":"2018","unstructured":"Etievant J, Si-Mohamed S, Vinurel N, Dupuis-Girod S, Decullier E, Gamondes D, et al. Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: correlations between computed tomography findings and cerebral complications. Eur Radiol. 2018;28:1338\u201344.","journal-title":"Eur Radiol"},{"key":"1337_CR36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.106.5.1387","volume":"106","author":"BA Ference","year":"1994","unstructured":"Ference BA, Shannon TM, White RI, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest. 1994;106:1387\u201390.","journal-title":"Chest."},{"key":"1337_CR37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/SMJ.0b013e318172f716","volume":"101","author":"B Sell","year":"2008","unstructured":"Sell B, Evans J, Horn D. CME topic brain abscess and hereditary hemorrhagic telangiectasia. South Med J. 2008;101:618\u201325.","journal-title":"South Med J"},{"key":"1337_CR38","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/ajmg.a.35622","volume":"158","author":"T Nishida","year":"2012","unstructured":"Nishida T, Faughnan ME, Krings T, Chakinala M, Gossage JR, Young WL, et al. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. Am J Med Genet. 2012;158:2829\u201334.","journal-title":"Am J Med Genet"},{"key":"1337_CR39","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/STROKEAHA.114.007367","volume":"46","author":"H Kim","year":"2015","unstructured":"Kim H, Nelson J, Krings T, ter Brugge KG, McCulloch CE, Lawton MT, et al. Brain vascular malformation consortium HHT Investigator Group. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke. 2015;46:1362\u20134.","journal-title":"Stroke."},{"key":"1337_CR40","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3174\/ajnr.A4762","volume":"37","author":"W Brinjikji","year":"2016","unstructured":"Brinjikji W, Iyer VN, Yamaki V, Lanzino G, Cloft HJ, Thielen KR, et al. Neurovascular manifestations of hereditary hemorrhagic telangiectasia: a consecutive series of 376 patients during 15 years. Am J Neuroradiol. AJNR Am J Neuroradiol. 2016;37:1479\u201386.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1337_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jocn.2018.01.019","volume":"51","author":"NT Gamboa","year":"2018","unstructured":"Gamboa NT, Joyce EJ, Eli I, Park MS, Taussky P, Schmidt RH, et al. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. J Clin Neurosci. 2018;51:22\u20138.","journal-title":"J Clin Neurosci"},{"key":"1337_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jmg.2005.035451","volume":"43","author":"TG Letteboer","year":"2006","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet. 2006;43:371\u20137.","journal-title":"J Med Genet"},{"key":"1337_CR43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/019459988409200511","volume":"92","author":"W Richtsmeier","year":"1984","unstructured":"Richtsmeier W, Weaver G, Streck W, Jacobson H, Dewell R, Olson J, et al. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 1984;92:564\u201370.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1337_CR44","first-page":"547","volume":"25","author":"H Pau","year":"2000","unstructured":"Pau H, Carney A, Walker R, Murty G. Is oestrogen therapy justifed in the treatment of hereditary haemorrhagic telangiectasia: a biochemical evaluation. Otolaryngol. 2000;25:547\u201350.","journal-title":"Otolaryngol."},{"key":"1337_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/00016489.2011.621145","volume":"132","author":"B Eivazi","year":"2012","unstructured":"Eivazi B, Werner JA, Roessler M, Negm H, Teymoortash A. Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis. Acta Otolaryngol. 2012;132:86\u20139.","journal-title":"Acta Otolaryngol"},{"key":"1337_CR46","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/ATVBAHA.118.310760","volume":"38","author":"E Alsina-Sanch\u00eds","year":"2018","unstructured":"Alsina-Sanch\u00eds E, Garc\u00eda-Ib\u00e1\u00f1ez Y, Figueiredo AM, Riera-Domingo C, Figueras A, Matias-Guiu X, et al. ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation. Arterioscler Thromb Vasc Biol. 2018;38:1216\u201329.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1337_CR47","first-page":"8","volume":"24","author":"A Iriarte","year":"2019","unstructured":"Iriarte A, Figueras A, Cerd\u00e0 P, Mora JM, Jucgl\u00e0 A, Pen\u00edn R, et al. PI3K (phosphatidylinositol 3-kinase) activation and endothelial cell proliferation in patients with hemorrhagic hereditary telangiectasia type 1. Cells. 2019;24:8.","journal-title":"Cells."},{"key":"1337_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13023-019-1239-6","volume":"14","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN. Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers. Orphanet J Rare Dis. 2019;14:256.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1337_CR49","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1172\/JCI127425","volume":"130","author":"Santiago Ruiz","year":"2020","unstructured":"Ruiz S, Zhao H, Chandakkar P, Papoin J, Choi H, Nomura-Kitabayashi A, et al. Correcting Smad1\/5\/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. J Clin Invest. 2020;130:942\u201357.","journal-title":"Journal of Clinical Investigation"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1337-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:37:59Z","timestamp":1614645479000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1337-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1337-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Clinical Research Ethics Committee of the Hospital Universitari de Bellvitge (Barcelona, Spain; ethic approval number PR098\/16).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form. Each patient was identified by a unique alphanumeric identification code and all data were made anonymous and analysed as aggregates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}